| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
603718 Stock Overview
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.
Shanghai Hile Bio-Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.85 |
| 52 Week High | CN¥16.83 |
| 52 Week Low | CN¥9.73 |
| Beta | 0.76 |
| 1 Month Change | -2.69% |
| 3 Month Change | -5.65% |
| 1 Year Change | -18.42% |
| 3 Year Change | -12.15% |
| 5 Year Change | -19.99% |
| Change since IPO | 154.38% |
Recent News & Updates
Shareholder Returns
| 603718 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.5% | 1.6% | 2.3% |
| 1Y | -18.4% | -17.5% | -11.7% |
Return vs Industry: 603718 underperformed the CN Pharmaceuticals industry which returned -16.7% over the past year.
Return vs Market: 603718 underperformed the CN Market which returned -11.4% over the past year.
Price Volatility
| 603718 volatility | |
|---|---|
| 603718 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in CN Market | 9.2% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 603718 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 603718's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 542 | Bin Su | https://www.hile-bio.com |
Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of porcine parvovirus disease; pathogenic porcine reproductive and respiratory syndrome live vaccines; transmissible gastroenteritis, porcine epidemic diarrhea, and porcine rotavirus triple live vaccines; porcine reproductive and respiratory syndrome live vaccines; swine transmissible gastroenteritis and swine epidemic diarrhea combined inactivated vaccines; porcine circovirus type 2 inactivated vaccines; and swine Japanese encephalitis live vaccines. It also provides chicken infectious bursal disease live vaccines; inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease and avian infectious bronchitis combined live vaccines; newcastle disease low virulent live vaccines; Marek's disease turkey herpes virus live vaccines; and fowlpox live vaccines.
Shanghai Hile Bio-Technology Co., Ltd. Fundamentals Summary
| 603718 fundamental statistics | |
|---|---|
| Market Cap | CN¥6.99b |
| Earnings (TTM) | CN¥51.01m |
| Revenue (TTM) | CN¥331.30m |
137.0x
P/E Ratio21.1x
P/S RatioIs 603718 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603718 income statement (TTM) | |
|---|---|
| Revenue | CN¥331.30m |
| Cost of Revenue | CN¥149.39m |
| Gross Profit | CN¥181.91m |
| Other Expenses | CN¥130.90m |
| Earnings | CN¥51.01m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.079 |
| Gross Margin | 54.91% |
| Net Profit Margin | 15.40% |
| Debt/Equity Ratio | 56.3% |
How did 603718 perform over the long term?
See historical performance and comparison